Recombinant Human Anti-PD-1 Monoclonal Antibody HX008 Injection for the Treatment of Advanced Solid Tumors
Clinical trial NCT03704246 · UNKNOWN
Trial details
- NCT number
- NCT03704246
- Sponsor
- Taizhou Hanzhong biomedical co. LTD
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-30
- Primary completion
- 2019-12-30
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.